Page last updated: 2024-10-24

positive regulation of motor neuron apoptotic process

Definition

Target type: biologicalprocess

Any process that activates or increases the frequency, rate or extent of motor neuron apoptotic process. [GOC:mtg_apoptosis, GOC:obol]

Positive regulation of motor neuron apoptotic process is a complex biological process that involves a series of molecular events leading to the programmed death of motor neurons. This process is tightly regulated and is essential for maintaining proper neuronal function and preventing neurodegenerative diseases. Here is a detailed description:

1. **Initiation of Apoptosis:**
- **Extrinsic Pathway:**
- Activation of death receptors (e.g., TNFR1, Fas) on the motor neuron surface by their respective ligands (e.g., TNF-alpha, FasL) triggers the formation of a death-inducing signaling complex (DISC).
- DISC recruits and activates caspase-8, which initiates the apoptotic cascade.
- **Intrinsic Pathway:**
- Stressful stimuli (e.g., oxidative stress, DNA damage, mitochondrial dysfunction) can activate pro-apoptotic proteins (e.g., Bax, Bak) within the motor neuron.
- These proteins permeabilize the mitochondrial membrane, releasing cytochrome c into the cytosol.
- Cytochrome c, together with apoptotic protease activating factor 1 (Apaf-1), forms the apoptosome complex, which activates caspase-9.

2. **Caspase Cascade:**
- Both caspase-8 and caspase-9 activate effector caspases (e.g., caspase-3, caspase-6, caspase-7).
- Effector caspases cleave various cellular proteins, leading to dismantling of the cell.

3. **Execution of Apoptosis:**
- Caspase-mediated cleavage of nuclear lamins disrupts the nuclear envelope.
- DNA fragmentation occurs due to caspase-activated DNase (CAD).
- Cellular blebbing occurs as the cell membrane breaks down into smaller fragments, called apoptotic bodies.

4. **Phagocytosis:**
- Apoptotic bodies are engulfed and removed by neighboring cells or macrophages, preventing inflammation.

5. **Regulation of Apoptosis:**
- Anti-apoptotic proteins (e.g., Bcl-2, Bcl-xL) can inhibit the intrinsic pathway by blocking mitochondrial permeability.
- Survival factors (e.g., nerve growth factor, insulin-like growth factor) can activate signaling pathways that inhibit apoptosis.

6. **Consequences of Dysregulation:**
- Excessive motor neuron apoptosis can lead to neurodegenerative diseases such as amyotrophic lateral sclerosis (ALS) and spinal muscular atrophy (SMA).
- Insufficient apoptosis can contribute to tumor formation and uncontrolled cell growth.

Positive regulation of motor neuron apoptotic process involves the enhancement or promotion of the molecular events described above. This can occur through various mechanisms, including:

- Increased expression or activity of pro-apoptotic proteins (e.g., Bax, Bak, caspase-8, caspase-9)
- Decreased expression or activity of anti-apoptotic proteins (e.g., Bcl-2, Bcl-xL)
- Activation of death receptors by their ligands
- Exposure of motor neurons to stressful stimuli that trigger the intrinsic apoptotic pathway

It is important to note that positive regulation of motor neuron apoptosis is a complex process involving multiple signaling pathways and regulatory mechanisms. Understanding these mechanisms is crucial for developing therapies that target specific pathways involved in motor neuron death and prevent the progression of neurodegenerative diseases.'
"

Proteins (1)

ProteinDefinitionTaxonomy
Apoptosis regulator BAX An apoptosis regulator BAX that is encoded in the genome of human. [PRO:SY, UniProtKB:Q07812]Homo sapiens (human)

Compounds (2)

CompoundDefinitionClassesRoles
vorinostatvorinostat : A dicarboxylic acid diamide comprising suberic (octanedioic) acid coupled to aniline and hydroxylamine. A histone deacetylase inhibitor, it is marketed under the name Zolinza for the treatment of cutaneous T cell lymphoma (CTCL).

Vorinostat: A hydroxamic acid and anilide derivative that acts as a HISTONE DEACETYLASE inhibitor. It is used in the treatment of CUTANEOUS T-CELL LYMPHOMA and SEZARY SYNDROME.
dicarboxylic acid diamide;
hydroxamic acid
antineoplastic agent;
apoptosis inducer;
EC 3.5.1.98 (histone deacetylase) inhibitor
abt-737aromatic amine;
aryl sulfide;
biphenyls;
C-nitro compound;
monochlorobenzenes;
N-arylpiperazine;
N-sulfonylcarboxamide;
secondary amino compound;
tertiary amino compound
anti-allergic agent;
anti-inflammatory agent;
antineoplastic agent;
apoptosis inducer;
B-cell lymphoma 2 inhibitor